National Cancer Grid

The initiative to bulk-buy drugs is led by the country’s largest cancer centre, Tata Memorial Hospital (TMH) in Mumbai. The initial list had 40 common off-patent generic drugs, covering 80% of their pharmacy costs, saving the group $170m.

The success of the scheme has attracted interest from hospitals and state governments across the country.

The next round will expand to over 100 drugs, while broader cancer care purchases like supplies, diagnostics and equipment are also being considered. However, more expensive patented treatments are currently not part of the plan.

“I think what pharmaceutical companies need to understand is in a market like India, unless you bring costs down, you’re not going to get the volumes and it’s a chicken and the egg phenomenon,” according to Dr C S Pramesh, Director of TMH and the Convenor of National Cancer Grid.

Disc: invested

Dec’23 toll revenue crosses 900 cr

Most of the corporates which were working remotely are now going back to working from offices. So repainting contracts from these clients, apart from the real estate boom will drive the growth for this company IMO. Also it is to be seen, if the management has any plans to manufacture SKK brand products in India instead of importing them.

To be very honest as of now it’s a basic Excel sheet. You can improve it by adding more KPIs and features that would be hard to track on Excel. The idea holds potential. Also, it’s better to think now, about how you’re going to monetize it.

Hello everyone,

I thought we should get connected to other Valuepickr’s around MADHYA PRADESH. The idea would be to meet periodically (ONLINE) and share ideas and issues relating to investing and learn from each other.